Tamoxifen-loaded novel liposomal formulations: evaluation of anticancer activity on DMBA-TPA induced mouse skin carcinogenesis

Liposomes for (trans)dermal delivery of tretinoin: influence of drug concentration and vesicle composition

(2015) M. Manconi et al.   JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases

(2011) D. Cosco et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Tamoxifen-encapsulated vesicular systems: cytotoxicity evaluation in human epidermal keratinocyte cell line

(2010) Amit Bhatia et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Novel drug delivery systems in topical treatment of psoriasis: Rigors and vigors

(2010) OmPrakash Katare et al.   Indian Journal of Dermatology Venereology & Leprology

Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin

(2010) Kaisar Raza et al.   JOURNAL OF DRUG TARGETING

Transcutol containing vesicles for topical delivery of minoxidil

(2010) Simona Mura et al.   JOURNAL OF DRUG TARGETING

Positron emission tomography imaging of DMBA/TPA mouse skin multi-step tumorigenesis

(2010) Tomo-o Ishikawa et al.   Molecular Oncology

Drug-Induced Ocular Disorders

(2009) Junping Li et al.   DRUG SAFETY

The rationale and potential of cancer chemoprevention with special emphasis on breast cancer

(2009) Matteo Puntoni et al.   EUROPEAN JOURNAL OF CANCER

Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: The ‘personalised’ approach?

(2009) Hiltrud Brauch et al.   EUROPEAN JOURNAL OF CANCER

Vesicular carriers for dermal drug delivery

(2009) Chiara Sinico et al.   Expert Opinion on Drug Delivery

Uterine sarcomas: A review

(2009) Emanuela D'Angelo et al.   GYNECOLOGIC ONCOLOGY

Therapeutic Potential of New 4-hydroxy-tamoxifen-Loaded pH-gradient Liposomes in a Multiple Myeloma Experimental Model

(2009) Giorgia Urbinati et al.   PHARMACEUTICAL RESEARCH

Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells

(2009) Sangmin Kim et al.   PHYTOMEDICINE

Evaluation of endometrial thickness in hormone receptor positive early stage breast cancer postmenopausal women switching from adjuvant tamoxifen treatment to anastrozole

(2008) Mario Valenzano Menada et al.   BREAST

Studies on tamoxifen encapsulated in lipid vesicles: Effect on the growth of human breast cancer MCF-7 cells

(2008) Amit Bhatia et al.   JOURNAL OF LIPOSOME RESEARCH

Evaluation of ovotoxicity induced by 7, 12-dimethylbenz[a]anthracene and its 3,4-diol metabolite utilizing a rat in vitro ovarian culture system

(2008) Yoshiyuki Igawa et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Tamoxifen is safe and effective in gynecological cancer patients with renal dysfunction

(2007) N. SIRISABYA et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER